Gabapentin Dementia Lawsuit | Early-Onset Dementia Claims Explained

The Gabapentin Dementia Lawsuit investigation involves potential claims from people who used gabapentin and were later diagnosed with early-onset dementia, mild cognitive impairment or other serious cognitive conditions. In this video, the attorneys at Zoll & Kranz explain the emerging litigation, the research raising questions about a possible association between repeated or long-term gabapentin use and cognitive problems and the factors attorneys may consider when reviewing a potential claim. Gabapentin is a prescription medication used for certain seizure disorders and nerve pain. It is available generically and under the brand name Neurontin. It is also commonly prescribed off-label for other conditions. Topics covered in this video include: What gabapentin is and why it is prescribed Concerns involving memory loss and cognitive decline Early-onset dementia and mild cognitive impairment What the emerging gabapentin lawsuits allege Research examining gabapentin and cognitive diagnoses Why an association does not prove causation Warning signs of dementia and cognitive impairment Why patients should not stop gabapentin without medical guidance Who may be considered for a potential lawsuit Medical and prescription records that may be important How a free gabapentin lawsuit evaluation works Whether the litigation is currently a class action A 2025 observational study discussed in the video reported higher rates of dementia diagnoses and mild cognitive impairment among certain patients who received multiple gabapentin prescriptions. However, the study identified an association and did not establish that gabapentin directly causes dementia. The litigation is still developing. Courts have not made a final determination that gabapentin causes dementia or that any manufacturer is legally responsible for an individual patient’s diagnosis. If you or a loved one used gabapentin and was later diagnosed with early-onset dementia, mild cognitive impairment or another serious cognitive condition, Zoll & Kranz is currently reviewing potential claims nationwide. Learn more about the Gabapentin Dementia Lawsuit or request a free case evaluation: https://toledolaw.com/gabapentin-deme... There are no upfront costs for qualifying cases and attorney fees are only paid if compensation is recovered. Important: Do not stop taking or change the dosage of gabapentin or any prescribed medication without first speaking with your healthcare provider. This video is for educational purposes only and does not constitute medical or legal advice. Every case is different and contacting the firm does not create an attorney-client relationship. #GabapentinLawsuit #Gabapentin #DementiaLawsuit #DrugInjury #ZollAndKranz 00:00 Gabapentin Early-Onset Dementia Lawsuit 00:25 What Is Gabapentin? 00:50 Gabapentin & Cognitive Injuries 01:51 What Is the Gabapentin Litigation About? 02:30 Research Linking Gabapentin & Cognitive Diagnoses 03:48 Dementia & Mild Cognitive Impairment Explained 05:03 Important Warning for Current Gabapentin Users 05:25 Who May Qualify for a Potential Claim? 06:20 Evidence for a Gabapentin Dementia Claim 06:47 How to Start a Potential Lawsuit 07:12 Is This a Gabapentin Class Action? 07:33 Contact Zoll & Kranz